Evaluating statin treatment in frail older patients after stroke or TIA
Official title: StAtins in Frail OldEr Patients with Ischemic Stroke or Transient Ischemic Attack - the Prospective Cohort Study
Run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · NCT06785740 · Data updated 2026-11-12
This study is testing whether keeping older, frail patients on statins after a stroke or TIA helps them feel better and avoid serious heart problems compared to stopping the medication.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 70 Years to 120 Years |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Academic / other |
| Locations | 4 sites (Almere Stad and 3 other locations) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | September 2029 |
| Study ends | September 2029 |
| Registry record updated | January 21, 2025 |
| Trial ID | NCT06785740 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are frail individuals aged 70 and older who have recently suffered an ischemic stroke or TIA and are currently on statin therapy.
✕Probably not a fit
Patients who are very frail with a life expectancy of less than six months or those with serious adverse reactions to statins will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the impact of continuing versus discontinuing statin therapy in frail individuals aged 70 and above who have recently experienced an ischemic stroke or transient ischemic attack (TIA). The study will follow participants for two years to evaluate their health-related quality of life and the incidence of major adverse cardiovascular events (MACE). Given the conflicting guidelines on statin use in older patients, this research seeks to fill the gap in evidence regarding the efficacy of statins in frail older adults. Participants will be assessed based on their frailty status using a validated scale.
Why it matters
Potential benefit: If successful, this study could provide critical insights into the optimal management of statin therapy in frail older patients, potentially improving their quality of life and reducing adverse cardiovascular events.
How similar studies have gone: While there is limited evidence specifically addressing frail older adults, previous studies have shown that statins can reduce major vascular events in older populations, indicating potential for success in this cohort.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age = 70 years or older at the time of ischemic stroke or TIA; * inclusion within 6 weeks after diagnosis of ischemic stroke or TIA; * already using statin therapy at the time of the index event; * frailty as defined by a pre-event score of 4-7 and/or post-event score of 6-7 on the validated Clinical Frailty Scale. Exclusion Criteria: * Previous serious adverse drug reactions (defined as an adverse reaction that results in death, is life-threatening, requires hospitalisation or prolongation of existing hospitalisa-tion, results in persistent or significant disability or incapacity, or is a birth defect32) to statins or other contraindications to statin use. * Very severe frailty or very limited life expectancy (\< 6 months) as defined by a score \>= 8 points on the validated Clinical Frailty Scale. * Inability to communicate in Dutch. * Inability to respond to questions, either independently or with the assistance of a proxy. * Inability or unwillingness to provide written informed consent, either independently or with the assistance of a proxy.
Where it's running
-
Flevoziekenhuis
Almere Stad, Netherlands Recruiting -
Amsterdam UMC, location AMC
Amsterdam, Netherlands Recruiting -
Catharina Ziekenhuis
Eindhoven, Netherlands Recruiting -
Isala Klinieken
Zwolle, Netherlands Recruiting
Study contacts
- Principal investigator: Renske van den Berg-Vos, Prof. dr. — Amsterdam UMC, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
- Study coordinator: Susanna R Prins, MSc
- Email: s.r.prins@amsterdamumc.nl
- Phone: 0031 20 566 9111
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using probucol to reduce recurrent strokes in patients with artery stenosis
This study is testing if a medication called probucol can help prevent strokes in people with narrowed arteries who are at risk for having another stroke.
-
Using platelet expression and blood flow analysis to predict recurrent stroke risk
This study is trying to see if certain blood cell markers and blood flow patterns can help predict the risk of having another stroke in people who have already had a minor stroke or a temporary stroke-like event.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Remote ischemic conditioning for post-stroke insomnia
A 136-person, randomized study will test whether a non-invasive arm-cuff procedure done twice daily for 90 days can improve sleep after a first ischemic stroke in adults 18–80.
-
Ear-based nerve stimulation to help sleep after a stroke
A device that delivers vagal nerve stimulation through the ear is tested to see if it helps stroke patients in rehab sleep better.
-
Theta Burst Stimulation to Help Stroke Recovery (Upper and Lower Limbs)
This trial tests whether applying theta burst stimulation to the motor cortex, in combination with standard rehabilitation, helps people over 45 who recently had a first ischemic stroke recover arm and leg movement.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.